Search research articles
Contact Us
Filters
Showing results (81-90 of 238) with videos related to
Page
of 24
Sort By:
Molecular Genetics and Metabolism Reports
|
August 31, 2019
Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease
Behshad Charkhand, Morris H Scantlebury, Aya Narita, et al.
Blood Cells, Molecules & Diseases
|
December 28, 2016
Classifying the additional morbidities of Gaucher disease
Mirjam Langeveld, Deborah Elstein, Jeff Szer, et al.
BMC Oral Health
|
July 24, 2003
Dental profile of patients with Gaucher disease
Stuart L Fischman, Deborah Elstein, Harold Sgan-Cohen, et al.
Journal of Clinical Gastroenterology
|
September 10, 2003
Amyloidosis and gastric bleeding in a patient with Gaucher disease
Deborah Elstein, Eliezer Rosenmann, Constantin Reinus, et al.
Blood Cells, Molecules & Diseases
|
April 2, 2003
Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease
Bernard Rudensky, Esther Paz, Gheona Altarescu, et al.
American Journal of Clinical Pathology
|
June 15, 2013
Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement
Ehud Lebel, Deborah Elstein, Ariel Peleg, et al.
Advanced Drug Delivery Reviews
|
June 28, 2022
Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease
Mia Horowitz, Hila Braunstein, Ari Zimran, et al.
Journal of Osteoporosis
|
December 16, 2014
Bone mineral density in gravida: effect of pregnancies and breast-feeding in women of differing ages and parity
Ehud Lebel, Yuri Mishukov, Liana Babchenko, et al.
Blood Cells, Molecules & Diseases
|
October 14, 2015
13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease
Deborah Elstein, Aya Abrahamov, Anat Oz, et al.
Blood Cells, Molecules & Diseases
|
November 19, 2016
UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease
Hila Braunstein, Gali Maor, Gaya Chicco, et al.
Page
of 24
Search research articles
Search
Showing results (81-90 of 238) with videos related to
Sort By:
Page
of 24
Molecular Genetics and Metabolism Reports
|
August 31, 2019
Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease
Behshad Charkhand, Morris H Scantlebury, Aya Narita, et al.
Blood Cells, Molecules & Diseases
|
December 28, 2016
Classifying the additional morbidities of Gaucher disease
Mirjam Langeveld, Deborah Elstein, Jeff Szer, et al.
BMC Oral Health
|
July 24, 2003
Dental profile of patients with Gaucher disease
Stuart L Fischman, Deborah Elstein, Harold Sgan-Cohen, et al.
Journal of Clinical Gastroenterology
|
September 10, 2003
Amyloidosis and gastric bleeding in a patient with Gaucher disease
Deborah Elstein, Eliezer Rosenmann, Constantin Reinus, et al.
Blood Cells, Molecules & Diseases
|
April 2, 2003
Fluorescent flow cytometric assay: a new diagnostic tool for measuring beta-glucocerebrosidase activity in Gaucher disease
Bernard Rudensky, Esther Paz, Gheona Altarescu, et al.
American Journal of Clinical Pathology
|
June 15, 2013
Histologic findings of femoral heads from patients with Gaucher disease treated with enzyme replacement
Ehud Lebel, Deborah Elstein, Ariel Peleg, et al.
Advanced Drug Delivery Reviews
|
June 28, 2022
Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease
Mia Horowitz, Hila Braunstein, Ari Zimran, et al.
Journal of Osteoporosis
|
December 16, 2014
Bone mineral density in gravida: effect of pregnancies and breast-feeding in women of differing ages and parity
Ehud Lebel, Yuri Mishukov, Liana Babchenko, et al.
Blood Cells, Molecules & Diseases
|
October 14, 2015
13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease
Deborah Elstein, Aya Abrahamov, Anat Oz, et al.
Blood Cells, Molecules & Diseases
|
November 19, 2016
UPR activation and CHOP mediated induction of GBA1 transcription in Gaucher disease
Hila Braunstein, Gali Maor, Gaya Chicco, et al.
Page
of 24